BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14557879)

  • 1. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.
    Mizoshita T; Tsukamoto T; Nakanishi H; Inada K; Ogasawara N; Joh T; Itoh M; Yamamura Y; Tatematsu M
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):727-34. PubMed ID: 14557879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa.
    Mizoshita T; Tsukamoto T; Inada K; Ogasawara N; Hirata A; Kato S; Joh T; Itoh M; Yamamura Y; Tatematsu M
    Pathol Int; 2004 Jun; 54(6):392-400. PubMed ID: 15144397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis.
    Fan Z; Li J; Dong B; Huang X
    Clin Cancer Res; 2005 Sep; 11(17):6162-70. PubMed ID: 16144916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdx2 expression in pancreatic tumors: Relationship with prognosis of invasive ductal carcinomas.
    Matsumoto K; Mizoshita T; Tsukamoto T; Ogasawara N; Hirata A; Shimizu Y; Haneda M; Yamao K; Tatematsu M
    Oncol Rep; 2004 Dec; 12(6):1239-43. PubMed ID: 15547744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.
    Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M
    Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells.
    Mizoshita T; Inada K; Tsukamoto T; Nozaki K; Joh T; Itoh M; Yamamura Y; Ushijima T; Nakamura S; Tatematsu M
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):29-36. PubMed ID: 14615935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
    Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M
    Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
    Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
    Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.
    Bai Z; Ye Y; Chen D; Shen D; Xu F; Cui Z; Wang S
    APMIS; 2007 Dec; 115(12):1383-90. PubMed ID: 18184409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
    Xiong ZF; Xiao H; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas.
    Almeida R; Silva E; Santos-Silva F; Silberg DG; Wang J; De Bolós C; David L
    J Pathol; 2003 Jan; 199(1):36-40. PubMed ID: 12474224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.
    Ge J; Chen Z; Wu S; Yuan W; Hu B; Chen Z
    Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
    Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
    Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic and small-intestinal phenotypes in gastric cancers: relationships with clinicopathological findings.
    Mizoshita T; Tsukamoto T; Tanaka H; Takenaka Y; Kato S; Cao X; Joh T; Tatematsu M
    Pathol Int; 2005 Oct; 55(10):611-8. PubMed ID: 16185290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications.
    Seno H; Oshima M; Taniguchi MA; Usami K; Ishikawa TO; Chiba T; Taketo MM
    Int J Oncol; 2002 Oct; 21(4):769-74. PubMed ID: 12239615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.
    Camilo V; Barros R; Celestino R; Castro P; Vieira J; Teixeira MR; Carneiro F; Pinto-de-Sousa J; David L; Almeida R
    BMC Cancer; 2014 Oct; 14():753. PubMed ID: 25300947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
    Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.
    Qin R; Wang NN; Chu J; Wang X
    World J Gastroenterol; 2012 Jul; 18(25):3296-302. PubMed ID: 22783055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells.
    Almeida R; Almeida J; Shoshkes M; Mendes N; Mesquita P; Silva E; Van Seuningen I; Reis CA; Santos-Silva F; David L
    J Pathol; 2005 Dec; 207(4):396-401. PubMed ID: 16278805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.
    Oz Puyan F; Can N; Ozyilmaz F; Usta U; Sut N; Tastekin E; Altaner S
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.